Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
Objective. To evaluate our experience with intravitreal melphalan chemotherapy as a second-line regimen for RB patients with refractory or recurrent vitreous seeds. Methods. A retrospective case series of 16 eyes from 16 patients with intraocular RB who received intravitreal melphalan chemotherapy u...
Main Authors: | Yacoub A. Yousef, Amal M. Noureldin, Iyad Sultan, Rasha Deebajah, Maysa Al-Hussaini, Munir Shawagfeh, Mustafa Mehyar, Mona Mohammad, Imad Jaradat, Ibrahim AlNawaiseh |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/8628525 |
Similar Items
-
Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
by: Yacoub A. Yousef, et al.
Published: (2021-07-01) -
Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome
by: Mustafa Mehyar, et al.
Published: (2020-09-01) -
Resistant retinoblastoma in a 23-year-old patient
by: Yacoub A Yousef, et al.
Published: (2014-01-01) -
Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
by: Nisha V. Shah, et al.
Published: (2014-01-01) -
Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
by: Xunda Ji, et al.
Published: (2016-01-01)